Below is a list of active grantees in the NINDS early translational therapeutic development funding opportunities (non-SBIR).
| Funding Announcement | Project No | PI | Institution | Project Title | Abstract | Indication |
|---|---|---|---|---|---|---|
| PAR-15-070 IGNITE Assay (R21/R33) |
NS094863 | McNamara, James | Duke University | Inhibitors of TrkB Signaling | RePORTER Abstract | Epilepsy |
|
PAR-15-071 |
NS094896 | Dave, Kunjan | University of Miami School of Medicine | Red blood cell microparticles (RMPs) to reduce bleeding following hemorrhagic stroke | RePORTER Abstract | Stroke |
| PAR-15-071 IGNITE PD/Efficacy (R21/R33) |
NS095139 | Androphy, Elliot | Indiana Univ-Purdue Univ at Indianapolis | Optimization of Compounds that Stabilize the SMN Protein for Treatment of SMA | RePORTER Abstract | Spinal Muscular Atrophy |
| PAR-14-058 HTS (R01) |
NS082198 | Hamm, Heidi | Vanderbilt University | Screening for allosteric modulators of the protease activated receptor 4 | RePORTER Abstract | Thrombosis |
|
PAR-14-058 |
NS085223 | Lasmezas, Corinne | Scripps Florida | High-throughput screening for NAD+-replenishing neuroprotective compounds | RePORTER Abstract | Neurodegenerative Diseases |
|
PAR-14-058 |
NS083937 | Bram, Richard | Mayo Clinic Rochester | High throughput screen for selective inhibitors of cyclophilin B | RePORTER Abstract | Brain Cancer |
|
PAR-14-058 |
NS080893 | Li, Dean | University of Utah | High Content Sceening for Hereditary Stroke Syndrome | RePORTER Abstract | Brain Cancer |